MedPath

广东泉新泉益药业有限公司

Ownership
-
Established
2001-04-26
Employees
-
Market Cap
-
Website
www.anbaojian.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253974
Approval Date
Apr 22, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253973
Approval Date
Apr 22, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249800
Approval Date
Dec 25, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249799
Approval Date
Dec 25, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249801
Approval Date
Dec 25, 2024
NMPA

Dapoxetine Hydrochloride Tablets

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20243157
Approval Date
Feb 6, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20233727
Approval Date
Jun 14, 2023
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20233726
Approval Date
Jun 14, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.